Granuflo, Fresenius Lawsuits Continue to Pile Up

Fresenius has not heard the end of it and needless to say, their patients never heard the beginning.  As of July 27, 2013, Fresenius Medical Care has acquired more than 300 lawsuits for the fatal side effects of their dialysis treatment, Granuflo.

Nonexistent Fine Print

Granuflo, manufactured by Fresenius Medical Care, was once a common dialysis treatment meant to neutralize acids that begin to build up in patient’s blood. Naturally, some of Granuflo’s ingredients are converted into bicarbonates which without proper monitoring, can result in metabolic alkalosis and its serious cardiac complications including cardiopulmonary arrest, heart attack, stroke, and death.

Affected patients and their families are taking legal action against Fresenius Medical Care for failing to inform Granuflo users of fatal side effects and risks.

Use the contact form to the right to learn how you can receive help for any losses/damages either you or a loved one has suffered.

Woodlock Moving Forward

A West Virginia husband is holding Fresenius Medical Care accountable for his wife’s sudden passing this July after she was exposed to Granuflo during her dialysis treatment. Her husband claims that Fresenius failed to properly label and inform their patients (and families) about the risks associated with Granuflo thus, resulting in a heart attack and sudden cardiac death.

The Granuflo lawsuits, very similar to the one shared above, are currently pending underway in the U.S. District Court, District of Massachusetts.  The presiding federal judge, Judge Douglas P. Woodlock, appointed attorneys to serve on the plaintiffs’ executive and steering committees. The executive committee is now responsible for the management of pretrial proceedings as well as the task of establishing direct committees to assist with case preparation.

Stay alerted about Fresenius and Granuflo lawsuit updates provided by Bad-Drug.net.